RxDoctor Payments DataLook up a doctor →

ARZERRA: payments to doctors

Payments that named ARZERRA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$195K
Providers
80
Transactions
279
Average per transaction
$699

The per-transaction average — $699 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 80 providers the average total is $2,438, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$111,64457.2%
Novartis$83,40942.8%
← All drugs & devices